Traber Peter G (CIK 0001284500)

Latest company ownership

RNAC - Cartesian Therapeutics, Inc.
Role: Chief Medical Officer
Shares held
451,826
Last filed at
Sep 26, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4
Shares held
100,000
Last filed at
Jun 15, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2012Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 25, 2023 Sep 26, 2023 Cartesian Therapeutics, Inc. Chief Medical Officer Sell 52.5 -705 -0.16% ✗ $747.3
Jan 4, 2023 Jan 6, 2023 Cartesian Therapeutics, Inc. Chief Medical Officer Sell 46.3 -11,644 -2.54% ✗ $13.2K
Jan 5, 2022 Jan 7, 2022 Cartesian Therapeutics, Inc. Chief Medical Officer Sell 47.5 -3,226 -1.27% ✗ $10K
Dec 10, 2021 Dec 14, 2021 Cartesian Therapeutics, Inc. Chief Medical Officer Sell 46.3 -4,083 -2.42% ✗ $12.2K
Oct 13, 2021 Oct 15, 2021 Cartesian Therapeutics, Inc. Chief Medical Officer Sell 46.3 -3,636 -2.30% ✗ $16K
May 26, 2021 May 27, 2021 Cartesian Therapeutics, Inc. Chief Medical Officer Buy 95.0 +20,000 17.32% ✗ $79.9K
May 24, 2021 May 26, 2021 Cartesian Therapeutics, Inc. Chief Medical Officer Buy 95.0 +17,500 17.86% ✗ $58.9K
Mar 17, 2021 Mar 19, 2021 Cartesian Therapeutics, Inc. Chief Medical Officer Buy 95.0 +20,000 25.64% ✗ $90.3K
Dec 14, 2020 Dec 16, 2020 Cartesian Therapeutics, Inc. Chief Medical Officer Buy 95.0 +40,000 100.00% ✗ $129.4K
Jun 13, 2018 Jun 15, 2018 GALECTIN THERAPEUTICS INC CEO Sell 7.5 -100,000 -48.23% ✓ $751K
Jun 8, 2018 Jun 12, 2018 GALECTIN THERAPEUTICS INC CEO Sell 7.5 -70,000 -39.47% ✓ $410K
Aug 12, 2015 Aug 12, 2015 GALECTIN THERAPEUTICS INC CEO Buy 77.5 +2,000 1.90% ✗ $4K
Jun 1, 2015 Jun 1, 2015 GALECTIN THERAPEUTICS INC CEO Buy 83.8 +4,000 3.95% ✗ $10.1K
Aug 14, 2014 Aug 15, 2014 GALECTIN THERAPEUTICS INC CEO Buy 83.8 +4,000 4.11% ✗ $17.8K
Aug 13, 2014 Aug 14, 2014 GALECTIN THERAPEUTICS INC CEO Buy 77.5 +1,000 1.04% ✗ $4.4K
Dec 9, 2013 Dec 10, 2013 GALECTIN THERAPEUTICS INC CEO Buy 67.5 +500 0.52% ✗ $4.5K
Dec 5, 2013 Dec 5, 2013 GALECTIN THERAPEUTICS INC CEO Buy 67.5 +500 0.52% ✗ $4.5K
Nov 19, 2013 Nov 19, 2013 GALECTIN THERAPEUTICS INC CEO Buy 77.5 +1,000 1.06% ✗ $5.5K
Nov 18, 2013 Nov 19, 2013 GALECTIN THERAPEUTICS INC CEO Buy 55.0 +1,000 0.20% ✗ $5.8K
Oct 12, 2012 Oct 15, 2012 GALECTIN THERAPEUTICS INC CEO Buy 60.0 +2,500 0.49% ✗ $5.3K
Oct 9, 2012 Oct 10, 2012 GALECTIN THERAPEUTICS INC CEO Buy 60.0 +2,500 0.50% ✗ $5K
Oct 8, 2012 Oct 9, 2012 GALECTIN THERAPEUTICS INC CEO Buy 78.8 +5,000 1.00% ✗ $10.4K